INTRODUCTION
a journal has been cited in a particular year or period. The annual JCR Impact Factor is a ratio between citations and recent citable items published. The Impact Factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years (1) . There is a lot of discussion going on about the real significance of IF, but it is used widely as an evaluation tool in many countries, including Serbia. The problem is that there is a feedback influence of the intensive IF use for journal evaluation, that effects the editorial practice in quite non-scientific way (2) . Important facts that should be considered are that IF is calculated from one commercial databaseThompson Reuters Web of Science -but from year 2006 onwards, it is not the only citation database (3, 4) . For biomedical sciences, the overlapping of existing citation databases is better than in other subjects, but it is far from complete. That could be very important for the evaluation of scientists from small scientific communities (5).
Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is,
JCR CATEGORY: ONCOLOGY
Experience has shown that in each specialty, the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the Scientists in Serbia are also evaluated according to the number of papers they published in leading journals of their discipline and according to the number of citations, their articles received. That is why we will show the details concerning leading journals in oncology from year 2000 to present, hoping to give relevant information to Serbian oncologists and help them to decide where to publish and which journals to consult. The other important fact is that the vast majority of journals on the list are published in USA or Great Britain, and even those that are not published there, are published in English. Only one journal from the list is published in German and five are multilingual, all the rest are published in English language. The data about the country of the publisher and publication language are presented in Table 2 . 
FIRST TEN JOURNALS FROM CATEGORY ONCOLOGY

WHERE TO SEND AN ARTICLE
It is important for every author, before deciding where to send an article, to consider also some important facts about journals included in the JCR listnot only what is the latest IF of the journal but also how many articles this journal publishes annually. Those data for the first 30% of the list for the year 2006 are given on the Table 3 . Table 3 shows that the number of published articles varies from 9 to 1493, so it is easy to conclude that there is much greater chance to get an article published in a journal that is not so extremely selective and publishes only a few articles a year, probably mostly reviews, then in a journal with a greater coverage of results in oncology.
CONCLUSION
Serbian scientists should consider also the distribution of the journal, availability in libraries and on the WWW, possibility to keep author rights and put the article in an open access repository, where it will get more attention from authors that do not have access to that journal, etc. The recent researches show that articles with open access to everybody on the WWW get much more citations than those published in journals with toll access (7) . The situation will be changing even more because US National Institute of public has access to the published results of NIH funded research. It requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital archive PubMed Central upon acceptance for publication. To help advance science and improve human health, the Policy requires that these papers are accessible to the public on PubMed Central no later importance in scientific communication process, because at the moment between 10 and 15% journals are in OA regime. Some of them, as for example journals that are published by PLoS (9) in the process of publishing good science is the role of Editor-in-Chief as he selects and organizes manuscripts for each journal issue, edits English language, chooses still and format, and coordinates with publisher. Finally, he has responsible task to publish each issue on time, and many times that task is the most significant (11).
